what is a glp-1 drug made from Glucagon-like peptide-1 Evolution of GLP‐1 Receptor Agonists

doi:10.1093/jnci/djv275 Luo J, Hendryx M, Manson JE, et al

The precise localization of GLP-1R expression in human lungs remains unclear (78)

World J Hepatol

They also slow progression of diabetic kidney disease and are associated with beneficial effects like lower blood pressure and improved lipid profiles ( [8] ) ( [7] )

Early Parkinsons trials have shown mixed results, and Alzheimers trials are In the intestine and joints, GLP-1 agonists reduce intestinal inflammation in colitis models and may benefit osteoarthritis by reducing synovitis and chondrocyte inflammation

#FDAApproval #ObesityManagement #GLP1 #ClinicalPharmacology #NewDrugApproval #WeightManagement #HealthcareInnovation #MedicalEducation #Orforglipron #Foundayo To view or add a comment, sign in Just as employers start to get their arms around GLP-1 costs the next wave is already hereand its more powerful